Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 1850 of 2400 entries
View as:

A Clinical Trial to Evaluate Safety, Tolerability, and Immunogenicity of Adjuvanted HIV-1 Fusion Peptide Conjugate Vaccine Alone or in Prime-Boost Regimens With Adjuvanted HIV-1 Envelope Trimer 4571 and HIV-1 Trimer 6931 Vaccines in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05470400 Org: User:
Start: 08/15/22 End: 01/24/24 Due: 01/24/25

A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea

Phase: N/A Priority: Normal
NCT ID: NCT00001018 Org: User:
Start: - End: - Due: -

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00991289 Org: User:
Start: 01/31/10 End: 01/31/12 Due: 01/31/13

Dressing Preparations for Smallpox

Phase: N/A Priority: Normal
NCT ID: NCT00063856 Org: User:
Start: 07/31/03 End: 06/30/04 Due: 06/30/05

Safety and Pharmacokinetics of Intravaginal Rings Containing Vicriviroc (MK-4176) and/or MK-2048

Phase: N/A Priority: Normal
NCT ID: NCT02356302 Org: User:
Start: 05/31/15 End: 03/31/16 Due: 03/31/17

HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China

Phase: N/A Priority: Normal
NCT ID: NCT00068991 Org: User:
Start: - End: 06/30/07 Due: 06/30/08

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00766597 Org: User:
Start: 08/31/09 End: 08/31/10 Due: 08/31/11

Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies

Phase: N/A Priority: Normal
NCT ID: NCT00311688 Org: User:
Start: 12/31/03 End: 12/31/08 Due: 12/31/09

Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT02330965 Org: User:
Start: 12/31/14 End: 07/12/17 Due: 07/12/18

Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT02178800 Org: User:
Start: 02/28/15 End: 07/13/18 Due: 07/13/19

Open Label Study to Evaluate Chronic Hepatitis C Treatment in Latino Subjects With and Without HIV Co-infection

Phase: N/A Priority: Normal
NCT ID: NCT01182298 Org: User:
Start: 07/31/10 End: 03/31/13 Due: 03/31/14

Higher Dose Intradermal H5 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00439335 Org: User:
Start: 03/31/07 End: 02/29/08 Due: 02/28/09

Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria Immunity

Phase: N/A Priority: Normal
NCT ID: NCT01160562 Org: User:
Start: 06/23/10 End: 01/23/13 Due: 01/23/14

Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected Lungs

Phase: N/A Priority: Normal
NCT ID: NCT00374517 Org: User:
Start: 09/05/06 End: 02/02/10 Due: 02/02/11

Combination Study With MVA BN and Dryvax

Phase: N/A Priority: Normal
NCT ID: NCT00082446 Org: User:
Start: 05/31/04 End: 08/31/07 Due: 08/31/08

Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects

Phase: N/A Priority: Normal
NCT ID: NCT04408950 Org: User:
Start: 11/12/20 End: 01/27/25 Due: 01/27/26

Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations

Phase: N/A Priority: Normal
NCT ID: NCT01430403 Org: User:
Start: 09/30/11 End: 03/31/14 Due: 03/31/15

Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies

Phase: N/A Priority: Normal
NCT ID: NCT00078195 Org: User:
Start: 04/30/03 End: 05/31/05 Due: 05/31/06

Examination of Protective Factors Against Severe Malaria

Phase: N/A Priority: Normal
NCT ID: NCT00342043 Org: User:
Start: 08/02/05 End: 04/16/09 Due: 04/16/10

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT03382834 Org: User:
Start: 04/26/18 End: 07/27/23 Due: 07/27/24

Challenge Infection of Healthy Adult Volunteers With RSV A2

Phase: N/A Priority: Normal
NCT ID: NCT03388645 Org: User:
Start: 02/20/18 End: 12/06/19 Due: 12/06/20

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

Phase: N/A Priority: Normal
NCT ID: NCT00307125 Org: User:
Start: 03/31/06 End: 12/31/12 Due: 12/31/13

Incidence of Group A Strep Pharyngitis in School Children in Fiji

Phase: N/A Priority: Normal
NCT ID: NCT00284882 Org: User:
Start: 01/31/06 End: 11/30/06 Due: 11/30/07

Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00056745 Org: User:
Start: - End: - Due: -

Chart Review of Antivirals for Influenza in Infants

Phase: N/A Priority: Normal
NCT ID: NCT00311701 Org: User:
Start: 11/30/05 End: 12/31/06 Due: 12/31/07